United States - English - NLM (National Library of Medicine)

hi-tech pharmacal co., inc. - trifluridine (unii: rmw9v5rw38) (trifluridine - unii:rmw9v5rw38) - trifluridine 10 mg in 1 ml - trifluridine ophthalmic solution, 1% (trifluridine ophthalmic solution) is indicated for the treatment of primary keratoconjunctivitis and recurrent epithelial keratitis due to herpes simplex virus, types 1 and 2. trifluridine ophthalmic solution, 1% is contraindicated for patients who develop hypersensitivity reactions or chemical intolerance to trifluridine.

United States - English - NLM (National Library of Medicine)

greenstone llc - trifluridine (unii: rmw9v5rw38) (trifluridine - unii:rmw9v5rw38) - trifluridine 1 g in 100 ml

United States - English - NLM (National Library of Medicine)

sandoz inc - trifluridine (unii: rmw9v5rw38) (trifluridine - unii:rmw9v5rw38) - indications and usage: trifluridine ophthalmic solution is indicated for the treatment of primary keratoconjunctivitis and recurrent epithelial keratitis due to herpes simplex virus, types 1 and 2. contraindications: trifluridine ophthalmic solution is contraindicated for patients who develop hypersensitivity reactions or chemical intolerance to trifluridine.

United States - English - NLM (National Library of Medicine)

taiho pharmaceutical co., ltd. - trifluridine (unii: rmw9v5rw38) (trifluridine - unii:rmw9v5rw38), tipiracil hydrochloride (unii: 4h59klq0a4) (tipiracil - unii:ngo10k751p) - trifluridine 15 mg - lonsurf, as a single agent or in combination with bevacizumab, is indicated for the treatment of adult patients with metastatic colorectal cancer previously treated with fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapy, an anti-vegf biological therapy, and if ras wild-type, an anti-egfr therapy. lonsurf is indicated for the treatment of adult patients with metastatic gastric or gastroesophageal junction adenocarcinoma previously treated with at least two prior lines of chemotherapy that included a fluoropyrimidine, a platinum, either a taxane or irinotecan, and if appropriate, her2/neu-targeted therapy. none. risk summary based on animal data and its mechanism of action [see clinical pharmacology (12.2)] , lonsurf can cause fetal harm. lonsurf caused embryo-fetal lethality and embryo-fetal toxicity in pregnant rats when given during gestation at doses resulting in exposures lower than or similar to human exposures at the recommended clinical dose (see data) . there are no available data on

United States - English - NLM (National Library of Medicine)

pfizer laboratories div pfizer inc - trifluridine (unii: rmw9v5rw38) (trifluridine - unii:rmw9v5rw38) - trifluridine 1 g in 100 ml

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

zuellig pharma sdn bhd - trifluridine; tipiracil hydrochloride -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

zuellig pharma sdn bhd - trifluridine; tipiracil hydrochloride -

Australia - English - Department of Health (Therapeutic Goods Administration)

servier laboratories (aust) pty ltd - trifluridine, quantity: 20 mg; tipiracil hydrochloride, quantity: 9.42 mg - tablet, film coated - excipient ingredients: purified talc; stearic acid; macrogol 8000; titanium dioxide; hypromellose; indigo carmine aluminium lake; iron oxide yellow; carnauba wax; magnesium stearate; lactose monohydrate; iron oxide red; shellac; pregelatinised maize starch - colorectal cancer lonsurf is indicated for the treatment of adult patients with metastatic colorectal cancer (mcrc) who have been previously treated with, or are not considered candidates for fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and anti-egfr agents.,gastric cancer lonsurf is indicated for the treatment of adult patients with metastatic gastric or gastroesophageal junction adenocarcinoma previously treated with at least two prior lines of chemotherapy that included a fluoropyrimidine, a platinum, either a taxane or irinotecan, and if appropriate, her2/neu-targeted therapy.

Canada - English - Health Canada

apotex inc - trifluridine - solution - 1% - trifluridine 1% - antivirals

Canada - English - Health Canada

sandoz canada incorporated - trifluridine - solution - 1% - trifluridine 1% - antivirals